2019

Avanir Pharmaceuticals has been in the news lately for its payment of kickbacks to physicians for its drug Nuedexta. On September…

In its upcoming fall Medical Education Exchange (MEDX) Primary Care 2019 Conferences, Rockpointe addresses the emerging threat of…

On September 29th, Thomas Stossel, one who inspired me to start Policy and Medicine, died working out at his local gym on Cape…

Late last year, a lawsuit was filed against the American Board of Internal Medicine (ABIM) by a group of internists, who argued…

On September 23, 2019, the House Ways & Means Committee released a report outlining and comparing the pharmaceutical pricing…

Senator Maggie Hassan of New Hampshire recently wrote an op-ed for Modern Healthcare in which she opined on the need for increased…

On September 25, 2019, the Senate Finance Committee, led by Chairman Chuck Grassley, released the text of its long-awaited bill…

The Centers for Medicare and Medicaid Services (“CMS”) announced that it will use its oft maligned “latent variable” methodology…

A few months ago, at the Blue Button Developers Conference  held at the White House, CMS announced plans to further the mission of…

Following a review of pharmaceutical advertising, the UK’s Prescription Medicines Code of Practice Authority (“PMCPA”) cited…